Cargando…
Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study
BACKGROUND: Pleiotropic effects have been implicated in clinical benefits of ticagrelor compared to thienopyridine P2Y(12) antagonists. There are conflicting data regarding effects of ticagrelor vs. thienopyridine P2Y(12) blockers on endothelial function. Our aim was to compare endothelial biomarker...
Autores principales: | Chyrchel, Bernadeta, Kruszelnicka, Olga, Surdacki, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670560/ https://www.ncbi.nlm.nih.gov/pubmed/36397167 http://dx.doi.org/10.1186/s12933-022-01685-4 |
Ejemplares similares
-
Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet Therapy
por: Chyrchel, Bernadeta, et al.
Publicado: (2023) -
Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study
por: Kruszelnicka, Olga, et al.
Publicado: (2016) -
Depressed systemic arterial compliance and impaired left ventricular midwall performance in aortic stenosis with concomitant type 2 diabetes: a retrospective cross-sectional study
por: Czestkowska, Ewa, et al.
Publicado: (2019) -
Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y(12) Receptor Antagonists
por: Chyrchel, Bernadeta, et al.
Publicado: (2019) -
Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor
por: Yun, Kyeong Ho, et al.
Publicado: (2019)